Cazzaniga, G., Schrappe, M., Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., et al. (2012). Role of MRD in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with and without Tirosine Kinase Inhibitor in the Esphall Study. BLOOD, 120(21) [10.1182/blood.V120.21.1467.1467].

Role of MRD in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with and without Tirosine Kinase Inhibitor in the Esphall Study

Cazzaniga, G;BIONDI, ANDREA
Penultimo
;
VALSECCHI, MARIA GRAZIA
Ultimo
2012

Abstract in rivista
MRD; Ph+ Pediatric Acute Lymphoblastic Leukemia; Esphall Study
English
2012
120
21
1467
none
Cazzaniga, G., Schrappe, M., Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., et al. (2012). Role of MRD in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with and without Tirosine Kinase Inhibitor in the Esphall Study. BLOOD, 120(21) [10.1182/blood.V120.21.1467.1467].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/74539
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact